102 related articles for article (PubMed ID: 10918437)
1. Successful autologous bone marrow transplant without the use of blood product support.
Ballen KK; Ford PA; Waitkus H; Emmons RV; Levy W; Doyle P; Stewart FM; Quesenberry PJ; Becker PS
Bone Marrow Transplant; 2000 Jul; 26(2):227-9. PubMed ID: 10918437
[TBL] [Abstract][Full Text] [Related]
2. Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience.
Mazza P; Prudenzano A; Amurri B; Palazzo G; Pisapia G; Stani L; Pricolo G
Bone Marrow Transplant; 2003 Aug; 32(4):433-6. PubMed ID: 12900781
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
[TBL] [Abstract][Full Text] [Related]
4. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemia in Jehovah's Witnesses: a challenge for hematologists.
Mazza P; Palazzo G; Amurri B; Cervellera M; Rizzo C; Maggi A
Haematologica; 2000 Nov; 85(11):1221-2. PubMed ID: 11064477
[No Abstract] [Full Text] [Related]
6. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patient.
Mahe B; Moreau P; Le Tortorec S; Hourmant M; Harousseau JL; Milpied N
Bone Marrow Transplant; 1994 Oct; 14(4):645-6. PubMed ID: 7858543
[TBL] [Abstract][Full Text] [Related]
8. [Objectives of a bloodless surgery program. A comparative study (major surgery vs. minor-medium surgery) in 51 Jehova's Witnesses patients].
Proposito D; Gramolini R; Corazza V; Mancini B; Gallina S; Montemurro L; Veltri S; Carboni M
Ann Ital Chir; 2002; 73(2):197-209; discussion 209-10. PubMed ID: 12197294
[TBL] [Abstract][Full Text] [Related]
9. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
10. Use of erythropoietin in Jehovah's Witness patients.
Jim RT
Hawaii Med J; 1990 Jun; 49(6):209. PubMed ID: 2397990
[No Abstract] [Full Text] [Related]
11. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
[TBL] [Abstract][Full Text] [Related]
12. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose?
Elfenbein GJ
Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
16. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
[TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
[TBL] [Abstract][Full Text] [Related]
18. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem-cell transplantation can be performed safely without the use of blood-product support.
Ballen KK; Becker PS; Yeap BY; Matthews B; Henry DH; Ford PA
J Clin Oncol; 2004 Oct; 22(20):4087-94. PubMed ID: 15353543
[TBL] [Abstract][Full Text] [Related]
20. ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.
Akhtar S; Tbakhi A; Humaidan H; El Weshi A; Rahal M; Maghfoor I
Bone Marrow Transplant; 2006 Feb; 37(3):277-82. PubMed ID: 16400345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]